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Abstract
Rationale: Acantholytic squamous cell carcinoma (ASCC) is an uncommon histopathologic variant of squamous cell carcinoma
(SCC), which is the most common malignancy of the oral cavity. Though ASCC showed poor prognosis, the exact diagnosis is
challenging.
Patientsconcerns:A 59-year-old female patient with 1-month long symptoms of pain and burning sensation in the right maxilla.
Diagnoses: Incisional biopsy in the maxilla established the pathologic diagnosis of SCC.
Intervention: The patient underwent mass resection with near total maxillectomy.
Outcomes: The final diagnosis through the microscopic examination was ASCC. Palliative chemotherapy was done to relive the
symptoms after the recurrence, however, the patient died of the disease at 8 months after her initial presentation.
Lessons: Special attention should be paid to this variant of SCC because most patients with ASCC have a very poor prognosis.
Abbreviations: ASCC= acantholytic squamous cell carcinoma, CT= computed tomography, MR=magnetic resonance, SCC=
squamous cell carcinoma.
Keywords:magnetic resonance imaging, prognosis, squamous cell carcinoma of head and neck, tomography, x-ray computed1. Introduction
Squamous cell carcinoma (SCC) is the most common malignancy
encountered in the oral cavity and has several histopathological
variants. Acantholytic SCC (ASCC) is an uncommon histopath-
ologic variant of SCC, which shows extensive acantholysis of
malignant epithelial cells, resulting in pseudovascular or
pseudoglandular appearance. Thus, it is also known as adenoid
SCC, pseudoglandular SCC, SCC with gland-like features,
angiosarcoma-like SCC, and pseudovascular adenoid SCC.[1]
It was first described in 1947, as a cutaneous adenoacanthomaEditor: Maya Saranathan.
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that originates from sweat glands;[2] however, subsequent studies
revealed that the lesion had a non-eccrine origin. Most of
reported ASCC cases were arising from the skin, especially in
the sun-exposed region.[3] Occurrences in upper aerodigestive
mucosa including lip, oral cavity, nasopharynx, and larynx has
been reported, and the first reported case in the oral cavity
mucosa was in 1977, by Goldman et al.[4] However, ASCC of
oral cavity were extremely rare with only 18 reported cases. The
differential diagnosis for intraoral ASCC includes adenosqu-
amous, adenoid cystic, and mucoepidermoid carcinomas of
minor salivary gland origin, as well as metastatic adenocarcino-
ma and angiosarcoma.[5]
Here we report the clinicoradiological features of a case with
ASCC in the maxilla, and review the available literature to reveal
the prognosis of this cancer variant.2. Case presentation
Ethical approval was waived by the institutional review board of
our hospital (ERI19042), because this study was a retrospective
case report and the patient was passed away. The husband of the
patient, her legal representative, provided the informed consent
to report the case.
A 59-year-old female patient with 1-month long symptoms of
pain and burning sensation in the right maxilla visited the
department of oral medicine at our hospital. Clinical examination
revealed an irregular hypertrophic lesion with a verrucous
erythematous surface and ulceration on the right palate and
edentulous gingiva of the right maxilla (Fig. 1). The pathology
result of an incisional biopsy sample reported SCC and
recommended re-sampling from a deeper portion of the lesion.
Thepatientwas referred to thedepartmentoforal andmaxillofacial
surgery where cancer work-up was performed for surgery.
Figure 1. Photographic image of the patient with a large mass having a
verrucous surface and ulceration on the right maxillary gingiva and palate.
Figure 2. Radiologic images showing an enhancing mass on the palate, destructin
images of contrast-enhanced CT with soft tissue window (a), with bone window
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Computed tomography (CT) and magnetic resonance (MR)
images revealed a well enhancing mass of approximately 38
3418mm in the right palate (Fig. 2). While destructing the
inferior aspect of the nasal cavity, the enhancing mass extended
across the midline along the palatal mucosa. The greater
palatine foramen was occupied by the mass, but evidence of
perineural spread into the pterygopalatine fossa was not found
on CT and MRI. No remarkable cervical lymph nodes were
observed.
The patient underwent mass resection with near total
maxillectomy, and the maxilla was reconstructed using a radial
forearm free flap. The total specimen was sent to the department
of oral pathology. Histopathologic examination revealed clear
margins of tumor cells. Nests of malignant squamous cells were
identified and showed marked acantholysis giving rise to
anastomosing spaces with pseudoglandular appearance
(Fig. 3). Immunohistochemical examinations were performed
to precisely diagnose the lesion (Fig. 4).Most neoplastic epithelial
cells were marked with pancytokeratin and p53, and the strongg the palatine process of the maxilla and infiltrating into the nasal cavity. Coronal
(b), T2-weighted MR (c), and postcontrast MR (d).
Figure 3. Microscopic images showing acantholysis of malignant squamous cells forming pseudoluminar or pseudoglandular structures [hematoxylin and eosin (a)
original magnification100, (b) original magnification200].
Kim et al. Medicine (2020) 99:32 www.md-journal.comstaining for Ki-67 represented the high proliferative activity of the
tumor cells. Although pseudoluminar spaces mimicking adenoid
features of a salivary gland tumor made the differential diagnosis
difficult, the neoplastic cells did not react with cytokeratin (CK) 7.
Based on all the above findings, a diagnosis of ASCC was made.Figure 4. Microscopic images showing immunohistochemistry result of acan
pancytokeratin and (b) p53 (original magnification100). (c) A high Ki-67 prolifer
pseudoglandular appearance are negative for cytokeratin 7 (original magnification
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Six weeks after the surgery, the patient underwent postopera-
tive radiotherapy (63 Gy, 28 cycles) for a month. Three weeks
after the radiotherapy, she visited our hospital with complaints of
ocular pain and swelling on the right side. Physiologic
examination revealed limitation of ocular movements and ptosistholytic squamous cell carcinoma. Tumor cells are immunoreactive for (a)
ative index is observed (original magnification100). (d) Tumor cells showing
200).
Figure 5. CT images of recurrent lesion. (a) A recurrent lesion destructing the cranial base adjacent to the upper resection margin of the previous surgery. Note the
intracranial invasion into the right cavernous sinus through perineural spread (b and c, dotted arrow). Another recurrent lesion in the medial pterygoid muscle (c,
double arrow).
Kim et al. Medicine (2020) 99:32 Medicineof the right upper eyelid. Subsequent CT revealed extensive
recurrent masses in the right pterygoid muscle and pterygopa-
latine fossa, destruction of the adjacent cranial base with
extension into the cavernous sinus, and superior orbital fissure
(Fig. 5). Palliative chemotherapy was initiated to relive the
symptoms; however, the patient died of the disease at 8 months
after her initial presentation.
3. Discussion
As a variant of SCC, ASCCs of the oral cavity are extremely rare
and need to be differentiated from adenosquamous carcinoma,
adenoid cystic carcinoma, mucoepidermoid carcinoma of minor
salivary gland origin, and metastatic adenocarcinoma and
angiosarcoma.[5] Microscopical features of ASCC include a
nonsolid component that contains single or grouped acantholytic
and dyskeratotic epithelial cells or cellular debris under theTable 1
Summary of reported cases of acantholytic squamous cell carcinom
Authors Age (yr) Sex Location
1 Goldman et al[4] 61 M Tongue
2 Takagi et al[11] 50 F Gingiva (maxillary premolar)
3 56 M Tongue
4 Zaatari and Santoianni[12] 86 M Gingiva (mandible)
5 Jones et al[13] 58 M Gingiva (lingual mucosa)
6 Kusafuka et al[5] 64 F Floor of mouth
7 Driemel et al[7] 58 F Gingiva (mandible)
8 57 M Tongue
9 68 M Tongue
10 50 M Floor of mouth
11 Kerawala[14] 56 M Tongue
12 Papadopoulou et al[6] 72 F Gingiva (maxillary premolar)
13 Prasad and Kaur[18] 70 F Gingiva (mandible)
14 Yeoh et al[8] 38 F Buccal mucosa
15 Nayak et al[15] 45 M Floor of mouth
16 53 M Gingiva (anterior maxilla)
17 Ozgursoy et al [16] 68 F Gingiva (anterior maxilla and palate)
18 Mardi and Singh[17] 50 M Gingiva (maxilla)
19 Present 59 F Gingiva (maxillary premolar and pala
DOD = died of disease, NED = no evidence of disease.
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conventional squamous cells, and this nonsolid component forms
pseudoglandular or pseudovascular structures. Markers useful
for tumor differentiation include the CK7+/CK20 for salivary
duct cells, which are negative in SCC cells,[6] and vascular
markers, which help distinguish angiosarcomas, although they
can appear histologically similar.
Our case exhibited a large recurrent tumor in just 2 months
after surgical treatment, with intracranial invasion through
perineural spread. The initial diagnostic images and pathological
examination from preoperative biopsy presented no remarkable
features to help us differentiate the lesion from conventional SCC,
and the resection margins around the tumor specimen after the
surgical procedure were clear of tumor cells. However, local
recurrence occurred very rapidly and widely despite postopera-
tive radiotherapy, and the patient died of the disease at 8 months
after her initial presentation. Our case with ASCC represented a
very grave prognosis.a in the oral mucosa.
Clinical features Recurrence (month) Follow-up (month)
Ulcerated nodular lesion 2 DOD at 8 Mo
Ulcer 18 DOD at 38 Mo
Erosion 26 DOD at 46 Mo
Nodular Tumor n/a n/a
Verrucous nodular lesion No NED (8)
Erosion, reddish mass No NED (5)




Ulcerated tumor 5 DOD at 9 Mo
Ulcerated tumor 10 DOD at 17 Mo
n/a n/a n/a
Ulcerated tumor 3 DOD at 7 Mo
Erythematous irregular swelling No NED (6 from RT)
Ulcerated lesion n/a (under tx.) n/a (under tx.)
Exophytic polypoid mass 1 DOD at 3Mo
Ulcerated tumor n/a n/a
te) Ulcerated, verrucous lesion 2 DOD at 8 Mo
Kim et al. Medicine (2020) 99:32 www.md-journal.comASCC has a poorer prognosis than conventional SCC, with a
more aggressive behavior and a greater risk for local recurrence
and metastasis.[2] However, because most reports regarding
ASCC have been tumors of sun-exposed skin, little is known
about the behavior of this variant of oral ASCC, and its prognosis
in mucosal sites is controversial. We reviewed English-language
literature on PubMed regarding ASCC in the oral cavity. Lesions
on the lip vermilion, which can be detected and treated earlier,
were excluded from our review. Nineteen ASCC cases in the
oral cavity, including the present case, have been reported
(Table 1).[4–8,10–18] The average age of the patients was 58 years
(range, 38 to 86 years). Of 19 patients, 8 were women and 11
weremen. Ten cases had lesions located in the gingival mucosa, 5
in the tongue, 3 in the mouth floor, and 1 in the buccal mucosa.
Except in 5 cases for which clinical features were not described,
the most frequent clinical characteristic was an ulcerative mass.
We found follow-up records of 11 reports, of which 8 had local
recurrences developed at 1 to 26months (mean, 8.4months) after
treatment and died of disease at 3 to 46 months (mean, 12.3
months) after the initial diagnosis (73%; 8 of 11 cases). One of
the 8 recurrent cases showedmetastasis into the lymph nodes at 1
month after surgery. Although the prognosis for patients with
mucosal ASCC remains controversial, our review of cases
suggests that this variant of cancer is more aggressive and has a
poorer prognosis than conventional SCC.[7] Alterations in the
expression of molecules such as E-cadherin and B-carotene,
which mediate cell–cell and cell–extracellular matrix adhesions,
have been associated with acantholysis and the aggressive
behavior of ASCCs.[8–10]
Diagnosing ASCC before performing a thorough pathological
examination is difficult because no specific macroscopic features
have been identified, and no pathognomonic imaging features are
observed. Our literature review and our experience with the
present case revealed a more aggressive behavior and poorer
prognosis for oral cavity ASCCs. With a diagnosis of ASCC, the
clinicians should consider an aggressive, multidisciplinary
treatment and a close follow-up with multimodality images to
improve patient outcomes.
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